YXYang Xia

Yang Xia

*This is an algorithmically generated author record based on publicly available information.

Yang Xia has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral Transport Characteristics and the Effects of Trigonelline With Contrast-Induced Acute Kidney Injury In Vivo and In Vitro

    by Renjie Xu, Ming ni, Aiping Wang, Feng Zhang, Haitao Pan, bin Yu, Haigang Ding, Lu Zhao, Yang Xia

    Background: Contrast-induced acute kidney injury (CI-AKI) and associated vascular endothelial damage represent significant clinical complications, yet effective preventive strategies remain limited. This study aims to investigate the protective efficacy of trigonelline against these injuries and elucidate its intestinal transport mechanisms to support its potential as a therapeutic agent. Methods: In this study, a contrast-induced acute kidney injury model was established in mice by tail vein injection of iohexol to investigate the kidney protective effects of trigonelline. Using a Caco-2 intestinal epithelial cell monolayer model, the transport characteristics of trigonelline and the involvement of potential transporters were systematically evaluated. Results: The concentration gradients of trigonelline used in the experiments showed no cytotoxic effects on Caco-2 cells. Trigonelline exhibited moderate intestinal absorption. The efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) were involved in the intestinal transport of trigonelline. Crucially, in the in vivo mouse model, trigonelline treatment significantly ameliorated iohexol-induced renal injury, evidenced by a dose-dependent reduction in serum creatinine and BUN levels, and a decrease in inflammatory cytokines (IL-6, TNF-α). Histopathological analysis confirmed that trigonelline effectively mitigated renal tubular necrosis and interstitial inflammation. Conclusion: The transport characteristics and potential vascular protective effects of trigonelline provide valuable insights for the design and development of therapeutic agents aimed at preventing contrast agent-induced vascular injury, and also contribute to a deeper understanding of the pharmacological activity of trigonelline.